FDA Advisory Committee on Psychopharmacologic Drugs Testimony Regarding Rexulti for PTSD Used Concurrently with Zoloft

July 18, 2025: We testify at FDA Advisory Committee about the lack of evidence that Rexulti combined with Zoloft treats PTSD better than Zoloft alone. Rexulti wants approval for PTSD to sell more product but it doesn't seem to work, and its side effects include suicidal thoughts and behaviors, weight gain, diarrhea, anxiety, uncontrolled body movements, diabetes, compulsive behaviors, and stroke.

The post FDA Advisory Committee on Psychopharmacologic Drugs Testimony Regarding Rexulti for PTSD Used Concurrently with Zoloft first appeared on National Center for Health Research.

The post FDA Advisory Committee on Psychopharmacologic Drugs Testimony Regarding Rexulti for PTSD Used Concurrently with Zoloft appeared first on National Center for Health Research.